A generic pharmaceutical manufacturer, Glenmark Pharmaceuticals Inc. USA (Glenmark), located in Mahwah, New Jersey, has agreed to pay $25 million, based on its ability to pay, to resolve its alleged liability under the False Claims Act for conspiring to fix the price of a generic drug. Read More
Home » Pharmaceutical Company Pays $25M to Resolve Alleged False Claims Act Liability for Price-Fixing of Generic Drug
Pharmaceutical Company Pays $25M to Resolve Alleged False Claims Act Liability for Price-Fixing of Generic Drug
Related Posts
Armed Drug Cartel Member Sentenced to Over 20 Years in Prison for
A Mexican national and armed member of the Cártel de Jalisco Nueva Generación (CJNG) was sentenced today in the District of Columbia to 20 years… BronArmed Drug Cartel Member Sentenced to Over 20 Years in Prison for
Israeli Freight Forwarder Sentenced to Two Years in Prison for
Gal Haimovich, 49, of Israel, was sentenced today to 24 months in prison and three years of supervised release for conspiracy to illegally ship aircraft… BronIsraeli Freight Forwarder Sentenced to Two Years in Prison for
Saad Healthcare Agrees to Pay $3M to Settle False Claims Act
Saad Enterprises Inc., doing business as Saad Healthcare, has agreed to pay $3 million to resolve allegations that it violated the False Claims Act by… BronSaad Healthcare Agrees to Pay $3M to Settle False Claims Act